Join our Expert Faculty as they discuss COVID-19 and your Bladder Cancer Patient

 Read More


Pharmacist Perspectives: Exploring the Evolving Role of BTK Inhibitors in CLL

Participants will gain exposure to emerging clinical and scientific advances in the treatment of chronic lymphocytic leukemia (CLL) with BTK inhibitors (BTKis), including novel pharmacologic targets within the B-cell receptor (BCR) pathway, and...

 Read More

Multiple Presenters Emily Dotson; Kathy Edwards;

For a listing of all of our oncology activities, click here

 Read More